Pearlman EM - Search Results

1

Comparing the Efficacy and Safety of Galcanezumab Versus Rimegepant for Prevention of Episodic Migraine: Results from a Randomized, Controlled Clinical Trial.

Schwedt TJ, Myers Oakes TM, Martinez JM, Vargas BB, Pandey H, Pearlman EM, Richardson DR, Varnado OJ, Cobas Meyer M, Goadsby PJ. Schwedt TJ, et al. Among authors: pearlman em. Neurol Ther. 2024 Feb;13(1):85-105. doi: 10.1007/s40120-023-00562-w. Epub 2023 Nov 10. Neurol Ther. 2024. PMID: 37948006 Free PMC article.

2

Factors and Reasons Associated with Hesitating to Seek Care for Migraine: Results of the OVERCOME (US) Study.

Shapiro RE, Muenzel EJ, Nicholson RA, Zagar AJ, L Reed M, Buse DC, Hutchinson S, Ashina S, Pearlman EM, Lipton RB. Shapiro RE, et al. Among authors: pearlman em. Neurol Ther. 2024 Nov 2. doi: 10.1007/s40120-024-00668-9. Online ahead of print. Neurol Ther. 2024. PMID: 39487945

3

Shapiro RE, Nicholson RA, Seng EK, Buse DC, Reed ML, Zagar AJ, Ashina S, Muenzel EJ, Hutchinson S, Pearlman EM, Lipton RB. Shapiro RE, et al. Among authors: pearlman em. Neurology. 2024 Feb 13;102(3):e208074. doi: 10.1212/WNL.0000000000208074. Epub 2024 Jan 17. Neurology. 2024. PMID: 38232340 Free PMC article.

4

Investigation of the Effect of Lasmiditan on the Pharmacokinetics of P-Glycoprotein and Breast Cancer Resistance Protein Substrates.

Luffer-Atlas D, Wilbraham D, Posada MM, Landry J, Tsai M, Pearlman EM. Luffer-Atlas D, et al. Among authors: pearlman em. J Clin Pharmacol. 2024 Jan;64(1):94-102. doi: 10.1002/jcph.2328. Epub 2023 Aug 24. J Clin Pharmacol. 2024. PMID: 37566903

5

Machine learning identifies factors most associated with seeking medical care for migraine: Results of the OVERCOME (US) study.

Ashina S, Muenzel EJ, Nicholson RA, Zagar AJ, Buse DC, Reed ML, Shapiro RE, Hutchinson S, Pearlman EM, Lipton RB. Ashina S, et al. Among authors: pearlman em. Headache. 2024 Sep;64(8):1027-1039. doi: 10.1111/head.14729. Epub 2024 May 24. Headache. 2024. PMID: 38785227

6

Diagnosis, consultation, treatment, and impact of migraine in the US: Results of the OVERCOME (US) study.

Lipton RB, Nicholson RA, Reed ML, Araujo AB, Jaffe DH, Faries DE, Buse DC, Shapiro RE, Ashina S, Cambron-Mellott MJ, Rowland JC, Pearlman EM. Lipton RB, et al. Among authors: pearlman em. Headache. 2022 Feb;62(2):122-140. doi: 10.1111/head.14259. Epub 2022 Jan 25. Headache. 2022. PMID: 35076091 Free PMC article.

7

A close association of freedom from pain, migraine-related functional disability, and other outcomes: results of a post hoc analysis of randomized lasmiditan studies SAMURAI and SPARTAN.

Lipton RB, Baygani SK, Tepper SJ, Krege JH, Vasudeva R, Pearlman EM, Hauck PM, Loo LS. Lipton RB, et al. Among authors: pearlman em. J Headache Pain. 2021 Aug 28;22(1):101. doi: 10.1186/s10194-021-01303-w. J Headache Pain. 2021. PMID: 34454420 Free PMC article.

8

Galcanezumab Provides Consistent Efficacy Throughout the Dosing Interval Among Patients with Episodic and Chronic Migraine: A Post Hoc Analysis.

Pozo-Rosich P, Samaan KH, Schwedt TJ, Nicholson RA, Rettiganti M, Pearlman EM. Pozo-Rosich P, et al. Among authors: pearlman em. Adv Ther. 2021 Jun;38(6):3154-3165. doi: 10.1007/s12325-021-01708-8. Epub 2021 May 5. Adv Ther. 2021. PMID: 33950375 Free PMC article. Clinical Trial.

9

Onset, Maintenance, and Cessation of Effect of Galcanezumab for Prevention of Migraine: A Narrative Review of Three Randomized Placebo-Controlled Trials.

Kuruppu DK, North JM, Kovacik AJ, Dong Y, Pearlman EM, Hutchinson SL. Kuruppu DK, et al. Among authors: pearlman em. Adv Ther. 2021 Mar;38(3):1614-1626. doi: 10.1007/s12325-021-01632-x. Epub 2021 Feb 5. Adv Ther. 2021. PMID: 33544305 Free PMC article. Review.

10

Medication overuse in a subgroup analysis of phase 3 placebo-controlled studies of galcanezumab in the prevention of episodic and chronic migraine.

Dodick DW, Doty EG, Aurora SK, Ruff DD, Stauffer VL, Jedynak J, Dong Y, Pearlman EM. Dodick DW, et al. Among authors: pearlman em. Cephalalgia. 2021 Mar;41(3):340-352. doi: 10.1177/0333102420966658. Epub 2020 Nov 3. Cephalalgia. 2021. PMID: 33143451 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23 results

Search Page

Filters